Published

Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychedelic medicine (New Rochelle, N.Y.)
Date: 2026-09-01
Source: PubMed
DOI: 10.1177/28314425251381806
PubMed: 42539773

Authors

Husein A Traylor M Vest MF Wood BJ Brogan M Thomas A McNeil S Bhuiyan MAN Hendricks P Kelly JR Gribben A Al-Qahtani MM Keys K Edinoff AN Patterson JC Murnane KS

Watch author

Derived topics and classifications

psilocybin Addiction Observational Study Safety Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.2026-09-01

Related papers

Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-20 Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?Psychedelics. · 2025-09-02 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26 Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disordersPsychedelics. · 2025-06-10 Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeedPsychedelics. · 2025-05-06